相关实验视频

Updated: Feb 28, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

脂质纳米颗粒使EGF能有效地传递mRNA,用于伤口愈合

Qunmei Zhou^1,2, Wenshang Liu¹, Junwen Ge¹

¹Department of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

|February 27, 2026

概括

这项研究开发了脂质纳米粒子 (LNP) 传递表皮生长因子 (EGF) mRNA,增强皮肤伤口愈合. 新的LNP-mRNA配方促进了EGF的持续表达,并有效地加速了组织的修复.

科学领域:

生物技术是生物技术.
再生医学是一种再生医学.
材料科学材料科学材料科学

背景情况:

皮肤伤口愈合往往因修复机制不足而受损.
重组表皮生长因子 (EGF) 显示出治疗潜力,但其半衰期短且不稳定.
目前的局限性阻碍了EGF用于有效治疗伤口的临床应用.

研究的目的:

开发一种脂质纳米粒子 (LNP) 传递系统,用于表皮生长因子 (EGF) mRNA.
为了实现持续的局部蛋白质表达,增强皮肤伤口愈合.
克服传统复合EGF治疗的局限性.

主要方法:

使用微流体,EGF mRNA被合成并封装到pH敏感的LNP中.
评估了LNP-mRNA_EGF的物理化学特性,稳定性和生物相容性.
实验室细胞研究和实验室小鼠全厚皮肤缺陷模型被用于评估治疗疗效.

主要成果:

在实验室中,LNP-mRNA_EGF表现出良好的稳定性和生物相容性,促进了EGF的持续表达和细胞增殖/迁移.
一次LNP-mRNA_EGF剂量在小鼠的第10天显著加快了伤口的关闭,表现优于对照组.
观察到增强的重新上皮质化,优化原沉积和上调的EGF/E-cadherin表达,没有系统性毒性.

结论:

基于LNP的EGF mRNA平台促进了从单剂量开始高效,持续的局部蛋白质表达.
这种方法为皮肤修复中的蛋白质替代疗法提供了一个有希望的策略.
该技术通过改进的再上皮质化和原重塑,显著加速伤口愈合.

关键词:

在EGF的mRNA.在LNP-mRNAEGFF中,原体重塑的重新塑造脂质纳米颗粒的使用方法伤口愈合伤口愈合

更多相关视频

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...